National Advisory Council for Healthcare Research and Quality: Request for Nominations for Public Members, 29082-29083 [2017-13396]
Download as PDF
29082
Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
Agency for Healthcare Research and
Quality
Dayna C. Brown,
Secretary and Clerk of the Commission.
National Advisory Council for
Healthcare Research and Quality:
Request for Nominations for Public
Members
[FR Doc. 2017–13545 Filed 6–23–17; 4:15 pm]
BILLING CODE 6715–01–P
FEDERAL RESERVE SYSTEM
mstockstill on DSK30JT082PROD with NOTICES
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than July 24, 2017.
A. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Bern Bancshares, Inc., Bern,
Kansas; to acquire up to 6.47 percent of
the voting shares of UBT Bancshares,
Inc., and thereby indirectly acquire
shares of United Bank & Trust, both in
Marysville, Kansas.
Board of Governors of the Federal Reserve
System, June 22, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
BILLING CODE 6210–01–P
VerDate Sep<11>2014
18:33 Jun 26, 2017
Jkt 241001
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of request for
nominations for public members.
AGENCY:
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
[FR Doc. 2017–13419 Filed 6–26–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Council advises the
Secretary of HHS (Secretary) and the
Director of the Agency for Healthcare
Research and Quality (AHRQ) on
matters related to activities of the
Agency to carry out its mission. AHRQ’s
mission is to produce evidence to make
health care safer, higher quality, more
accessible, equitable, and affordable,
and to work within the U.S. epartment
of Health and Human Services and with
other partners to make sure that the
evidence is understood and used. Seven
current members’ terms will expire in
November 2017
DATES: Nominations should be received
on or before 60 days after date of
publication.
SUMMARY:
Nominations should be sent
to Jaime Zimmerman AHRQ, 5600
Fishers Lane, 06E37A, Rockville,
Maryland 20857. Nominations may also
be emailed to NationalAdvisory
Council@ahrq.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, AHRQ, at (301) 427–
1456.
SUPPLEMENTARY INFORMATION: 42 U.S.C.
299c establishes a National Advisory
Council for Healthcare Research and
Quality (the Council) and provides that
the Secretary shall appoint to the
National Advisory Council for
Healthcare Research and Quality twenty
one appropriately qualified individuals.
At least seventeen members shall be
representatives of the public and at least
one member shall be a specialist in the
rural aspects of one or more of the
professions or fields listed in the above
summary. In addition, the Secretary
designates, as ex officio members,
representatives from other Federal
agencies, principally agencies that
conduct or support health care research,
as well as Federal officials the Secretary
may consider appropriate. 42 U.S.C.
299c(c)(3). Consistent with revised
guidance regarding the ban on lobbyists
serving as members of advisory boards
and commissions, AHRQ will accept
nominations for Federally registered
ADDRESSES:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
lobbyists to serve on the Council in a
representative capacity.
The Council meets in the Washington,
DC, metropolitan area, generally in
Rockville, Maryland, approximately
three times a year to provide broad
guidance to the Secretary and AHRQ’s
Director on the direction of and
programs undertaken by AHRQ.
Seven individuals will be selected by
the Secretary to serve on the Council
beginning with the meeting in the
spring of 2018. Members generally serve
3-year terms. Appointments are
staggered to permit an orderly rotation
of membership. To fill these positions,
we are seeking individuals with
experience and success in (1) the
conduct of research, demonstration
projects, and evaluations with respect to
health care; (2) the fields of health care
quality research or health care
improvement; (3) the practice of
medicine; (4) other health professions;
(5) representing the private health care
sector (including health plans,
providers, and purchasers) or
administrators of health care delivery
systems; (6) the fields of health care
economics, information systems, law,
ethics, business, or public policy; and,
(7) representing the interests of patients
and consumers of health care.
Interested persons may nominate one
or more qualified persons for
membership on the Council. Selfnominations are accepted. Nominations
shall include: (1) A copy of the
nominee’s resume or curriculum vitae;
and (2) a statement that the nominee is
willing to serve as a member of the
Council. Selected candidates will be
asked to provide detailed information
concerning their financial interests,
consultant positions and research grants
and contracts, to permit evaluation of
possible sources of conflict of interest.
Please note that once a candidate is
nominated, AHRQ may consider that
nomination for future positions on the
Council.
The Department seeks a broad
geographic representation. In addition,
AHRQ conducts and supports research
concerning priority populations, which
include: Low-income groups; minority
groups; women; children; the elderly;
and individuals with special health care
needs, including individuals with
disabilities and individuals who need
chronic care or end-of-life health care.
See 42 U.S.C. 299(c). Nominations of
persons with expertise in health care for
E:\FR\FM\27JNN1.SGM
27JNN1
Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices
these priority populations are
encouraged.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2017–13396 Filed 6–26–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces a meeting of the
National Advisory Council for
Healthcare Research and Quality.
DATES: The meeting will be held on
Wednesday, July 26, 2017, from 8:30
a.m. to 2:45 p.m.
ADDRESSES: The meeting will be held at
AHRQ, 5600 Fishers Lane, Rockville,
Maryland, 20857.
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
Rockville, Maryland 20857, (301) 427–
1456. For press-related information,
please contact Alison Hunt at (301) 427–
1244 or Alison.Hunt@ahrq.hhs.gov.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
Wednesday, July 19, 2017. The agenda,
roster, and minutes will be available
from Ms. Bonnie Campbell, Committee
Management Officer, Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Rockville, Maryland
20857. Ms. Campbell’s phone number is
(301) 427–1554.
SUPPLEMENTARY INFORMATION:
SUMMARY:
mstockstill on DSK30JT082PROD with NOTICES
I. Purpose
The National Advisory Council for
Healthcare Research and Quality is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
VerDate Sep<11>2014
18:33 Jun 26, 2017
Jkt 241001
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
On Wednesday, July 26, 2017, there
will be a subcommittee meeting for the
National Healthcare Quality and
Disparities Report scheduled to begin at
7:30 a.m. This meeting is open to the
public. The Council meeting will
convene at 8:30 a.m., with the call to
order by the Council Chair and approval
of previous Council summary notes. The
meeting is open to the public and will
be available via webcast at
www.webconferences.com/ahrq. The
meeting will begin with an update on
AHRQ’s current research, programs, and
initiatives. The agenda will also include
an update on AHRQ’s work in learning
health care systems and AHRQ’s
EvidenceNOW initiative, and will focus
on the use of AHRQ data and analytics
to answer emerging policy questions.
The final agenda will be available on the
AHRQ Web site at www.AHRQ.gov no
later than Wednesday, July 19, 2017.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2017–13393 Filed 6–26–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Drug Therapy for Early
Rheumatoid Arthritis in Adults—An
Update
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review of
Drug Therapy for Early Rheumatoid
Arthritis in Adults—An Update, which
is currently being conducted by the
SUMMARY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
29083
AHRQ’s Evidence-based Practice
Centers (EPC) Program. Access to
published and unpublished pertinent
scientific information will improve the
quality of this review.
DATES: Submission Deadline on or
before July 27, 2017.
ADDRESSES: Email submissions:
SEADS@epc-src.org.
Print submissions:
Mailing Address: Portland VA
Research Foundation, Scientific
Resource Center, ATTN: Scientific
Information Packet Coordinator, P.O.
Box 69539, Portland, OR 97239.
Shipping Address (FedEx, UPS, etc.):
Portland VA Research Foundation,
Scientific Resource Center, ATTN:
Scientific Information Packet
Coordinator, 3710 SW U.S. Veterans
Hospital Road, Mail Code: R&D 71,
Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT:
Ryan McKenna, Telephone: 503–220–
8262 ext. 51723 or Email: SEADS@epcsrc.org.
SUPPLEMENTARY INFORMATION: AHRQ is
conducting this systematic review
pursuant to Section 902(a) of the Public
Health Service Act, 42 U.S.C. 299a(a).
The Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Drug Therapy for Early
Rheumatoid Arthritis in Adults—An
Update.
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Drug Therapy for Early
Rheumatoid Arthritis in Adults—An
Update, including those that describe
adverse events. The entire research
protocol, including the key questions, is
also available online at: https://effective
healthcare.ahrq.gov/search-for-guidesreviews-and-reports/?pageaction=
displayproduct&productID=2475.
This is to notify the public that the
EPC Program would find the following
information on Drug Therapy for Early
Rheumatoid Arthritis in Adults—An
Update helpful:
D A list of completed studies that
your organization has sponsored for this
indication. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov,
E:\FR\FM\27JNN1.SGM
27JNN1
Agencies
[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Pages 29082-29083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13396]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
National Advisory Council for Healthcare Research and Quality:
Request for Nominations for Public Members
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of request for nominations for public members.
-----------------------------------------------------------------------
SUMMARY: The Council advises the Secretary of HHS (Secretary) and the
Director of the Agency for Healthcare Research and Quality (AHRQ) on
matters related to activities of the Agency to carry out its mission.
AHRQ's mission is to produce evidence to make health care safer, higher
quality, more accessible, equitable, and affordable, and to work within
the U.S. epartment of Health and Human Services and with other partners
to make sure that the evidence is understood and used. Seven current
members' terms will expire in November 2017
DATES: Nominations should be received on or before 60 days after date
of publication.
ADDRESSES: Nominations should be sent to Jaime Zimmerman AHRQ, 5600
Fishers Lane, 06E37A, Rockville, Maryland 20857. Nominations may also
be emailed to NationalAdvisoryCouncil@ahrq.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, AHRQ, at (301) 427-
1456.
SUPPLEMENTARY INFORMATION: 42 U.S.C. 299c establishes a National
Advisory Council for Healthcare Research and Quality (the Council) and
provides that the Secretary shall appoint to the National Advisory
Council for Healthcare Research and Quality twenty one appropriately
qualified individuals. At least seventeen members shall be
representatives of the public and at least one member shall be a
specialist in the rural aspects of one or more of the professions or
fields listed in the above summary. In addition, the Secretary
designates, as ex officio members, representatives from other Federal
agencies, principally agencies that conduct or support health care
research, as well as Federal officials the Secretary may consider
appropriate. 42 U.S.C. 299c(c)(3). Consistent with revised guidance
regarding the ban on lobbyists serving as members of advisory boards
and commissions, AHRQ will accept nominations for Federally registered
lobbyists to serve on the Council in a representative capacity.
The Council meets in the Washington, DC, metropolitan area,
generally in Rockville, Maryland, approximately three times a year to
provide broad guidance to the Secretary and AHRQ's Director on the
direction of and programs undertaken by AHRQ.
Seven individuals will be selected by the Secretary to serve on the
Council beginning with the meeting in the spring of 2018. Members
generally serve 3-year terms. Appointments are staggered to permit an
orderly rotation of membership. To fill these positions, we are seeking
individuals with experience and success in (1) the conduct of research,
demonstration projects, and evaluations with respect to health care;
(2) the fields of health care quality research or health care
improvement; (3) the practice of medicine; (4) other health
professions; (5) representing the private health care sector (including
health plans, providers, and purchasers) or administrators of health
care delivery systems; (6) the fields of health care economics,
information systems, law, ethics, business, or public policy; and, (7)
representing the interests of patients and consumers of health care.
Interested persons may nominate one or more qualified persons for
membership on the Council. Self-nominations are accepted. Nominations
shall include: (1) A copy of the nominee's resume or curriculum vitae;
and (2) a statement that the nominee is willing to serve as a member of
the Council. Selected candidates will be asked to provide detailed
information concerning their financial interests, consultant positions
and research grants and contracts, to permit evaluation of possible
sources of conflict of interest. Please note that once a candidate is
nominated, AHRQ may consider that nomination for future positions on
the Council.
The Department seeks a broad geographic representation. In
addition, AHRQ conducts and supports research concerning priority
populations, which include: Low-income groups; minority groups; women;
children; the elderly; and individuals with special health care needs,
including individuals with disabilities and individuals who need
chronic care or end-of-life health care. See 42 U.S.C. 299(c).
Nominations of persons with expertise in health care for
[[Page 29083]]
these priority populations are encouraged.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2017-13396 Filed 6-26-17; 8:45 am]
BILLING CODE 4160-90-P